Monday, January 18, 2021

Tag: Revive Therapeutics

Mesoblast Crashed on Poor DSMB Report Leaving CytoDyn as Sole Survivor...

Only Mesoblast (NASDAQ:MESO) and CytoDyn Inc. (OTCMKS: CYDY) had mortality as a primary endpoint in severe to critical COVID-19.